SYTRON

This brand name is authorized in Estonia, United Kingdom

Active ingredients

The drug SYTRON contains one active pharmaceutical ingredient (API):

1
UNII 403J23EMFA - SODIUM FEREDETATE
 

Sodium feredetate is used for iron deficiency anaemia. After absorption, elemental iron is available for haemoglobin regeneration and reversal of anaemia associated with iron-deficient states.
 
Read more about Sodium feredetate

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 SYTRON Oral solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B03A Iron preparations B Blood and blood forming organs → B03 Antianemic preparations
Discover more medicines within B03A

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1695135
GB Medicines & Healthcare Products Regulatory Agency 24884

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈